Cargando…

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma

BACKGROUND: Cuproptosis, one of the newest forms of cell death induction, is attracting mounting attention. However, the role of cuproptosis in lung cancer is currently unclear. In this study, we constructed a prognostic signature utilizing cuproptosis-related long noncoding RNAs (CRL) in lung adeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qixuan, Wang, Tianyi, Zhu, Jiaqi, Zhang, Anping, Wu, Anqi, Zhou, Youlang, Shi, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061461/ https://www.ncbi.nlm.nih.gov/pubmed/37007546 http://dx.doi.org/10.21037/atm-22-3195

Ejemplares similares

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023)

A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
por: Zhang, Tong, et al.
Publicado: (2023)

Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Liangping, et al.
Publicado: (2022)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
por: Chu, Binxiang, et al.
Publicado: (2022)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023)

A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022)

Construction of a Prognostic Model for Predicting Colorectal Cancer Prognosis and Response to Immunotherapy Based on Cuproptosis-Associated lncRNAs
por: Yang, Yi, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
por: Wu, Xiwen, et al.
Publicado: (2023)

Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Zhou, Jianghong, et al.
Publicado: (2023)

Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer
por: Ma, Zhihui, et al.
Publicado: (2023)

Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma
por: Chen, Jin-Hua, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer
por: Li, Ding, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
por: Zhu, Zhonglin, et al.
Publicado: (2022)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
por: Liu, Li, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in alimentary tract malignancies
por: Xie, Yangyang, et al.
Publicado: (2023)

Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853
por: Chen, Leifeng, et al.
Publicado: (2023)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients
por: Wang, Yanling, et al.
Publicado: (2023)

Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma
por: Li, Gang, et al.
Publicado: (2022)

The role of LncRNAs in tumor immunotherapy
por: Pan, Xuan, et al.
Publicado: (2023)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
por: Zhu, Hongfei, et al.
Publicado: (2022)

Distinct tumor microenvironment landscapes in gastric cancer classified by cuproptosis-related lncRNAs
por: Huang, Jianfeng, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fq0rnte9e988i5trujm4l4d9m4